by ChristinaSilva | Mar 21, 2022 | Blog
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York City,...
by Nicholas Baudoin | Mar 21, 2022 | 2022
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York...